PAR paradigm biopharmaceuticals limited..

The Ghosh Study - PART 1, page-19

  1. 4,841 Posts.
    lightbulb Created with Sketch. 7528
    Well Beaza, Im happy and sad at the same time.

    Sad that we don't have a deal yet and we have had to wait for oh so long

    Happy that we have a drug that will address a major unmet need and is so broad acting. It's value goes up literally by the month, especially when we start dosing in the P3. The securing of financing will not only be one of the biggest milestones commercially and from a validation stand point, it will pivot us totally and many doors will eventually open.

    My thoughts.



 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
31.0¢
Change
0.020(6.90%)
Mkt cap ! $120.7M
Open High Low Value Volume
29.0¢ 31.0¢ 28.0¢ $97.62K 331.4K

Buyers (Bids)

No. Vol. Price($)
2 74197 28.5¢
 

Sellers (Offers)

Price($) Vol. No.
31.0¢ 54675 2
View Market Depth
Last trade - 16.10pm 17/06/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.